Cortex
Pharmaceuticals About
Cortex Pharmaceuticals Cortex Pharmaceuticals, Inc. is
a biotechnology company engaged in the discovery, development and commercialization
of a novel technology called AMPAKINE® compounds, which already have shown
proof-of-principal efficacy in human clinical trials. AMPAKINE®
compounds enhance memory and cognition and impact disorders ranging from
early childhood such as autism, fragile X syndrome and Attention Deficit Hyperactivity
Disorder to age associated memory impairment disorders as seen in older populations,
such as Alzheimer’s disease and MCI.
NIH
TRIAL FOR AMPAKINE
More on Cortex Pharmaceuticals